Shanghai Kai Kai Industry Co Ltd B (900943) - Total Liabilities
Based on the latest financial reports, Shanghai Kai Kai Industry Co Ltd B (900943) has total liabilities worth $878.36 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shanghai Kai Kai Industry Co Ltd B - Total Liabilities Trend (2015–2024)
This chart illustrates how Shanghai Kai Kai Industry Co Ltd B's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Shanghai Kai Kai Industry Co Ltd B to evaluate short-term liquidity relative to the company's equity base.
Shanghai Kai Kai Industry Co Ltd B Competitors by Total Liabilities
The table below lists competitors of Shanghai Kai Kai Industry Co Ltd B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
XPLUS SA ZY -01
F:75R
|
Germany | €24.41 Million |
|
Union Community Co. Ltd
KQ:203450
|
Korea | ₩21.63 Billion |
|
Precipio Inc
NASDAQ:PRPO
|
USA | $7.40 Million |
|
Sharps Technology Inc
NASDAQ:STSS
|
USA | $10.75 Million |
|
Quilter PLC
LSE:QLT
|
UK | GBX75.08 Billion |
|
Dare Bioscience Inc
NASDAQ:DARE
|
USA | $29.63 Million |
|
Pantaflix AG
XETRA:PAL
|
Germany | €52.66 Million |
|
Danhua Chemical Technology Co Ltd B
SHG:900921
|
China | $913.28 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Shanghai Kai Kai Industry Co Ltd B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Kai Kai Industry Co Ltd B (900943) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Kai Kai Industry Co Ltd B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Kai Kai Industry Co Ltd B (2015–2024)
The table below shows the annual total liabilities of Shanghai Kai Kai Industry Co Ltd B from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $835.87 Million | +16.17% |
| 2023-12-31 | $719.52 Million | +14.39% |
| 2022-12-31 | $629.00 Million | +21.80% |
| 2021-12-31 | $516.43 Million | -1.19% |
| 2020-12-31 | $522.67 Million | +0.42% |
| 2019-12-31 | $520.47 Million | +0.82% |
| 2018-12-31 | $516.24 Million | -4.35% |
| 2017-12-31 | $539.69 Million | +1.61% |
| 2016-12-31 | $531.13 Million | +3.45% |
| 2015-12-31 | $513.44 Million | -- |
About Shanghai Kai Kai Industry Co Ltd B
Shanghai Kai Kai Industry Company Limited engages in the wholesale and retail of pharmaceutical products in China. The company engages in the wholesale and retail of traditional Chinese and Western medicines; medical devices; reagents; consumables and diagnosis; and treatment services, etc. under the Shang Lei brand, as well as production and sale of Chinese patent medicine under the Jing and Que… Read more